Possible treatment strategy identified for bone marrow failure syndrome (IMAGE)
Caption
A new study from Washington University School of Medicine in St. Louis identifies a possible treatment strategy for some bone marrow failure syndromes. Shown are human embryonic stem cells engineered to have a mutation that causes poikiloderma with neutropenia, a bone marrow failure syndrome that increases a patient's risk of developing dangerous infections.
Credit
BATISTA LAB
Usage Restrictions
None
License
Original content